Exact Mass: 495.33484100000004
Exact Mass Matches: 495.33484100000004
Found 72 metabolites which its exact mass value is equals to given mass value 495.33484100000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
LysoPC(16:0/0:0)
C24H50NO7P (495.33247200000005)
LysoPC(16:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(16:0), in particular, consists of one chain of palmitic acid at the C-1 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(16:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(16:0), in particular, consists of one chain of palmitic acid at the C-1 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
LysoPC(0:0/16:0)
C24H50NO7P (495.33247200000005)
LysoPC(0:0/16:0) is a lysophosphatidylcholine, which is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2 as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. There is also a phospholipase A1, which is able to cleave the sn-1 ester bond. Lysophosphatidylcholine has pro-inflammatory properties in vitro and it is known to be a pathological component of oxidized lipoproteins (LDL) in plasma and of atherosclerotic lesions. Recently, it has been found to have some functions in cell signalling, and specific receptors (coupled to G proteins) have been identified. It activates the specific phospholipase C that releases diacylglycerols and inositol triphosphate with resultant increases in intracellular Ca2+ and activation of protein kinase C. It also activates the mitogen-activated protein kinase in certain cell types. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPC(0:0/16:0), in particular, consists of one chain of palmitic acid at the C-2 position.
1-Nonadecanoyl-glycero-3-phosphoethanolamine
C24H50NO7P (495.33247200000005)
1-Palmitoylphosphatidylcholine
C24H50NO7P (495.33247200000005)
dysoxyhainanin A
C31H45NO4 (495.33484100000004)
A pentacyclic triterpenoid with a rearranged oleanane skeleton isolated from the whole plants of Dysoxylum hainanense. It exhibits antibacterial activity against Gram-positive bacteria.
PC(16:0/0:0)
C24H50NO7P (495.33247200000005)
CONFIDENCE standard compound; INTERNAL_ID 121 COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Lysophosphatidylcholines, egg
C24H50NO7P (495.33247200000005)
LPC 16:0
C24H50NO7P (495.33247200000005)
Annotation level-2
1-Palmitoyl-sn-glycero-3-phosphocholine
C24H50NO7P (495.33247200000005)
LysoPhosphatidylcholine_16_0
C24H50NO7P (495.33247200000005)
1-Palmitoyllysophosphatidylcholine
C24H50NO7P (495.33247200000005)
Platelet-activating factor
C24H50NO7P (495.33247200000005)
16:0 LYSO-PC
C24H50NO7P (495.33247200000005)
PC(16:0/0:0)[S]
C24H50NO7P (495.33247200000005)
PC(16:0/0:0)[U]
C24H50NO7P (495.33247200000005)
PC(0:0/16:0)
C24H50NO7P (495.33247200000005)
Palmi
C24H50NO7P (495.33247200000005)
LPE O-19:1;O
C24H50NO7P (495.33247200000005)
buta-1,3-diene,2-ethylhexyl prop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enenitrile,styrene
C31H45NO4 (495.33484100000004)
N-hexanoylphytosphingosine 1-phosphate
C24H50NO7P (495.33247200000005)
(2-Octanoyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C24H50NO7P (495.33247200000005)
[(2S)-2-hexadecanoyloxy-3-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] propanoate
C24H50NO7P (495.33247200000005)
(2-Heptanoyloxy-3-nonoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] octanoate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] decanoate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] hexanoate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] nonanoate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] heptanoate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] undecanoate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] acetate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] butanoate
C24H50NO7P (495.33247200000005)
(3-Decoxy-2-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C24H50NO7P (495.33247200000005)
(2-Butanoyloxy-3-dodecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C24H50NO7P (495.33247200000005)
(2-Propanoyloxy-3-tridecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C24H50NO7P (495.33247200000005)
(2-Pentanoyloxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C24H50NO7P (495.33247200000005)
(2-Acetyloxy-3-tetradecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C24H50NO7P (495.33247200000005)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] pentanoate
C24H50NO7P (495.33247200000005)
N(2)-acetylgentamycin C1a(4+)
Tetracation of N(2)-acetylgentamycin C1a.
2-Palmitoyl-sn-glycero-3-phosphocholine
C24H50NO7P (495.33247200000005)
A lysophosphatidylcholine 16:0 in which the acyl group is specified as palmitoyl (hexadecanoyl) and is located at position 2.
1-tetradecyl-2-acetyl-sn-glycero-3-phosphocholine
C24H50NO7P (495.33247200000005)
A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as tetradecyl.
1-nonadecanoyl-glycero-3-phosphoethanolamine
C24H50NO7P (495.33247200000005)
1-(2-methoxy-6Z-octadecenyl)-sn-glycero-3-phosphoethanolamine
C24H50NO7P (495.33247200000005)
lysophosphatidylcholine 16:0
C24H50NO7P (495.33247200000005)
A lysophosphatidylcholine in which the acyl group has a fully saturated C16 chain and is attached to the glycero moiety at either position 1 or 2.
Lysophosphatidylcholine(0:0/16:0)
C24H50NO7P (495.33247200000005)
A 2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group contains 16 carbons and is fully saturated.
1-hexadecanoyl-sn-glycero-3-phosphocholine
C24H50NO7P (495.33247200000005)
A lysophosphatidylcholine 16:0 in which a hexadecanoyl (palmitoyl) group is attached to the glycero moiety at position 1.
LdMePE(17:0)
C24H50NO7P (495.33247200000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(19:0)
C24H50NO7P (495.33247200000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2-{[(2r)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium
C24H50NO7P (495.33247200000005)